In Slovenia, primary acellular pertussis vaccines (ACVs) containing pertactin (PRN) were mostly used during 1999-2016; ACVs without PRN were introduced in 2017. Among 123 Bordetella pertussis strains collected during 2002-2020, a total of 48 were PRN-deficient; 44 were collected after 2017. Changes to ACVs could increase PRN-deficient B. pertussis and infections.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521159 | PMC |
| http://dx.doi.org/10.3201/eid3011.231393 | DOI Listing |
Publication Analysis
Top Keywords
bordetella pertussis
8
prevalence pertactin-deficient
4
pertactin-deficient bordetella
4
pertussis
4
pertussis isolates
4
isolates slovenia
4
slovenia slovenia
4
slovenia primary
4
primary acellular
4
acellular pertussis
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!